Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Bidirectional relationship between opioids and disrupted sleep: putative mechanisms.

Eacret D, Veasey SC, Blendy JA.

Mol Pharmacol. 2020 Mar 20. pii: mol.119.119107. doi: 10.1124/mol.119.119107. [Epub ahead of print]

2.

Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models.

Owen JE, Veasey SC.

Neurobiol Dis. 2020 Feb 19;139:104820. doi: 10.1016/j.nbd.2020.104820. [Epub ahead of print] Review.

3.

Obstructive Sleep Apnea in Adults. Reply.

Veasey SC, Rosen IM.

N Engl J Med. 2019 Jul 18;381(3):e7. doi: 10.1056/NEJMc1906527. No abstract available.

PMID:
31314987
4.

Obstructive Sleep Apnea in Adults.

Veasey SC, Rosen IM.

N Engl J Med. 2019 Apr 11;380(15):1442-1449. doi: 10.1056/NEJMcp1816152. Review. No abstract available.

PMID:
30970189
5.

Dietary challenges differentially affect activity and sleep/wake behavior in mus musculus: Isolating independent associations with diet/energy balance and body weight.

Perron IJ, Keenan BT, Chellappa K, Lahens NF, Yohn NL, Shockley KR, Pack AI, Veasey SC.

PLoS One. 2018 May 10;13(5):e0196743. doi: 10.1371/journal.pone.0196743. eCollection 2018.

6.

Obstructive sleep apnea drug therapy: apnea-hypopnea index leaves us high and dry.

Veasey SC.

Sleep. 2018 Jan 1;41(1). doi: 10.1093/sleep/zsy014. No abstract available.

PMID:
29361189
7.

Tumor necrosis factor alpha in sleep regulation.

Rockstrom MD, Chen L, Taishi P, Nguyen JT, Gibbons CM, Veasey SC, Krueger JM.

Sleep Med Rev. 2018 Aug;40:69-78. doi: 10.1016/j.smrv.2017.10.005. Epub 2017 Nov 17. Review.

8.

Neural Consequences of Chronic Short Sleep: Reversible or Lasting?

Zhao Z, Zhao X, Veasey SC.

Front Neurol. 2017 May 31;8:235. doi: 10.3389/fneur.2017.00235. eCollection 2017. Review.

10.

Degeneration in Arousal Neurons in Chronic Sleep Disruption Modeling Sleep Apnea.

Zhu Y, Fenik P, Zhan G, Xin R, Veasey SC.

Front Neurol. 2015 May 26;6:109. doi: 10.3389/fneur.2015.00109. eCollection 2015.

11.

Essential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survival.

Beier UH, Angelin A, Akimova T, Wang L, Liu Y, Xiao H, Koike MA, Hancock SA, Bhatti TR, Han R, Jiao J, Veasey SC, Sims CA, Baur JA, Wallace DC, Hancock WW.

FASEB J. 2015 Jun;29(6):2315-26. doi: 10.1096/fj.14-268409. Epub 2015 Feb 13.

12.

Long-term intermittent hypoxia elevates cobalt levels in the brain and injures white matter in adult mice.

Veasey SC, Lear J, Zhu Y, Grinspan JB, Hare DJ, Wang S, Bunch D, Doble PA, Robinson SR.

Sleep. 2013 Oct 1;36(10):1471-81. doi: 10.5665/sleep.3038.

13.
14.

Direct activation of sleep-promoting VLPO neurons by volatile anesthetics contributes to anesthetic hypnosis.

Moore JT, Chen J, Han B, Meng QC, Veasey SC, Beck SG, Kelz MB.

Curr Biol. 2012 Nov 6;22(21):2008-16. doi: 10.1016/j.cub.2012.08.042. Epub 2012 Oct 25.

15.

Piecing together phenotypes of brain injury and dysfunction in obstructive sleep apnea.

Veasey SC.

Front Neurol. 2012 Oct 9;3:139. doi: 10.3389/fneur.2012.00139. eCollection 2012.

16.

Daytime sleepiness in obesity: mechanisms beyond obstructive sleep apnea--a review.

Panossian LA, Veasey SC.

Sleep. 2012 May 1;35(5):605-15. doi: 10.5665/sleep.1812. Review.

17.

Neurobiology and neuropathophysiology of obstructive sleep apnea.

Li Y, Veasey SC.

Neuromolecular Med. 2012 Sep;14(3):168-79. doi: 10.1007/s12017-011-8165-7. Epub 2011 Dec 15. Review.

PMID:
22169915
18.

mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia.

Krymskaya VP, Snow J, Cesarone G, Khavin I, Goncharov DA, Lim PN, Veasey SC, Ihida-Stansbury K, Jones PL, Goncharova EA.

FASEB J. 2011 Jun;25(6):1922-33. doi: 10.1096/fj.10-175018. Epub 2011 Mar 2.

19.

Neural injury in sleep apnea.

Lim DC, Veasey SC.

Curr Neurol Neurosci Rep. 2010 Jan;10(1):47-52. doi: 10.1007/s11910-009-0078-6. Review.

PMID:
20425226
20.

Pathophysiology of sleep apnea.

Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP.

Physiol Rev. 2010 Jan;90(1):47-112. doi: 10.1152/physrev.00043.2008. Review. Erratum in: Physiol Rev.2010 Apr;90(2):797-8.

21.

Eif-2a protects brainstem motoneurons in a murine model of sleep apnea.

Zhu Y, Fenik P, Zhan G, Sanfillipo-Cohn B, Naidoo N, Veasey SC.

J Neurosci. 2008 Feb 27;28(9):2168-78. doi: 10.1523/JNEUROSCI.5232-07.2008.

22.

An essential role for orexins in emergence from general anesthesia.

Kelz MB, Sun Y, Chen J, Cheng Meng Q, Moore JT, Veasey SC, Dixon S, Thornton M, Funato H, Yanagisawa M.

Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1309-14. doi: 10.1073/pnas.0707146105. Epub 2008 Jan 14.

23.

Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model.

Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey SC.

J Neurosci. 2007 Sep 12;27(37):10060-71.

24.

Sedating, not treating sleep apnea: hit & run in primary care.

Veasey SC.

J Clin Sleep Med. 2005 Oct 15;1(4):372-3. No abstract available.

PMID:
17564404
25.

ACGME housestaff duty hours: enforced, yet not delivering rested physicians-in-training.

Veasey SC.

Sleep Med. 2007 Jan;8(1):10-1. Epub 2006 Dec 8. No abstract available.

PMID:
17158091
26.
27.

Sex differences in susceptibility to oxidative injury and sleepiness from intermittent hypoxia.

Sanfilippo-Cohn B, Lai S, Zhan G, Fenik P, Pratico D, Mazza E, Veasey SC.

Sleep. 2006 Feb;29(2):152-9.

PMID:
16494082
28.

Obstructive sleep apnea: re-evaluating our index of severity.

Veasey SC.

Sleep Med. 2006 Jan;7(1):5-6. Epub 2005 Nov 28. No abstract available.

PMID:
16310409
29.

Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.

Zhang B, Veasey SC, Wood MA, Leng LZ, Kaminski C, Leight S, Abel T, Lee VM, Trojanowski JQ.

Am J Pathol. 2005 Nov;167(5):1361-9.

30.

NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea.

Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC.

Am J Respir Crit Care Med. 2005 Oct 1;172(7):921-9. Epub 2005 Jun 30.

31.

Inducible nitric oxide synthase in long-term intermittent hypoxia: hypersomnolence and brain injury.

Zhan G, Fenik P, Pratico D, Veasey SC.

Am J Respir Crit Care Med. 2005 Jun 15;171(12):1414-20. Epub 2005 Mar 4.

32.

Will we ever have an effective pharmacotherapy for obstructive sleep apnea?

Veasey SC.

Sleep. 2005 Jan;28(1):18-9. No abstract available.

PMID:
15700716
33.

Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output.

Veasey SC, Zhan G, Fenik P, Pratico D.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):665-72. Epub 2004 Jun 30.

PMID:
15229096
34.

Murine Multiple Sleep Latency Test: phenotyping sleep propensity in mice.

Veasey SC, Yeou-Jey H, Thayer P, Fenik P.

Sleep. 2004 May 1;27(3):388-93.

PMID:
15164889
35.

Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions.

Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, Pratico D, Gow A.

Sleep. 2004 Mar 15;27(2):194-201.

PMID:
15124711
36.
37.

Molecular and physiologic basis of obstructive sleep apnea.

Veasey SC.

Clin Chest Med. 2003 Jun;24(2):179-93. Review.

PMID:
12800777
38.

Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus.

Fenik P, Veasey SC.

Am J Respir Crit Care Med. 2003 Feb 15;167(4):563-9. Epub 2002 Aug 22.

PMID:
12406845
39.

Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse.

Kapfhamer D, Valladares O, Sun Y, Nolan PM, Rux JJ, Arnold SE, Veasey SC, Bućan M.

Nat Genet. 2002 Oct;32(2):290-5. Epub 2002 Sep 16.

PMID:
12244319
40.
41.
42.

Pharmacotherapies for obstructive sleep apnea: how close are we?

Veasey SC.

Curr Opin Pulm Med. 2001 Nov;7(6):399-403. Review.

PMID:
11706315
43.

Physician, heal thyself: sleep, fatigue, and medical education.

Owens JA, Veasey SC, Rosen RC.

Sleep. 2001 Aug 1;24(5):493-5. No abstract available.

PMID:
11480647
44.

Pontine injections of nitric oxide synthase inhibitor l-name consolidate episodes of rem sleep in the rat.

Okabe S, Sanford LD, Veasey SC, Kubin L.

Sleep Res Online. 1998;1(1):41-8.

PMID:
11382856
45.

Serotonin. Culprit or promising therapy for obstructive sleep apnea?

Veasey SC.

Am J Respir Crit Care Med. 2001 Apr;163(5):1045-7. No abstract available.

PMID:
11316630
46.

The effects of ondansetron on sleep-disordered breathing in the English bulldog.

Veasey SC, Chachkes J, Fenik P, Hendricks JC.

Sleep. 2001 Mar 15;24(2):155-60.

PMID:
11247051
47.

An automated system for recording and analysis of sleep in mice.

Veasey SC, Valladares O, Fenik P, Kapfhamer D, Sanford L, Benington J, Bucan M.

Sleep. 2000 Dec 15;23(8):1025-40.

PMID:
11145318
48.

The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog.

Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC.

Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1659-67.

PMID:
10556137
49.

Single-unit responses of serotonergic dorsal raphe neurons to specific motor challenges in freely moving cats.

Veasey SC, Fornal CA, Metzler CW, Jacobs BL.

Neuroscience. 1997 Jul;79(1):161-9.

PMID:
9178872
50.

WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.

Fornal CA, Metzler CW, Gallegos RA, Veasey SC, McCreary AC, Jacobs BL.

J Pharmacol Exp Ther. 1996 Aug;278(2):752-62.

PMID:
8768728

Supplemental Content

Loading ...
Support Center